CAR T cell therapy involves genetically modifying a patient's own T cells to attack and kill cancer cells. These therapies represent a new treatment approach for certain types of cancer. CAR T cells are collected from a patient's own blood and are genetically modified to recognize a specific protein on the surface of cancer cells, allowing the CAR T cells to locate and destroy those cancer cells. Three CAR T cell therapies have been approved by the U.S. Food and Drug Administration for the ... Read more
CAR T cell therapy is an immunotherapy that helps the immune system fight cancers like leukemia and lymphoma. CAR T cell therapy involves collecting T cells from a patient and genetically modifying them with a chimeric antigen receptor (CAR) that directs the T cells to identify and attack cancer cells that have a specific protein on their surface. The modified CAR T cells are then infused back into the patient to trigger an immune response against the cancer. With high rates of remission for ... Read more
CAR T cell therapy is an evolving method of immunotherapy to treat cancers. It involves collecting T cells from a patient and genetically engineering them to express chimeric antigen receptors (CARs) that bind to specific proteins on tumor cells. The modified CAR T cells are infused back into patients to activate the immune system to eliminate cancer cells. CAR T cell therapy offers the potential of long-term remission for cancers like lymphoma and leukemia.
